Department of Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
MR Application Predevelopment, Siemens Healthineers GmbH, Erlangen, Germany.
Eur Radiol. 2024 Nov;34(11):7053-7062. doi: 10.1007/s00330-024-10776-7. Epub 2024 May 23.
To establish and evaluate an ultra-fast MRI screening protocol for prostate cancer (PCa) in comparison to the standard multiparametric (mp) protocol, reducing scan time and maintaining adequate diagnostic performance.
This prospective single-center study included consecutive biopsy-naïve patients with suspected PCa between December 2022 and March 2023. A PI-RADSv2.1 conform mpMRI protocol was acquired in a 3 T scanner (scan time: 25 min 45 sec). In addition, two deep-learning (DL) accelerated sequences (T2- and diffusion-weighted) were acquired, serving as a screening protocol (scan time: 3 min 28 sec). Two readers evaluated image quality and the probability of PCa regarding PI-RADSv2.1 scores in two sessions. The diagnostic performance of the screening protocol with mpMRI serving as the reference standard was derived. Inter- and intra-reader agreements were evaluated using weighted kappa statistics.
We included 77 patients with 97 lesions (mean age: 66 years; SD: 7.7). Diagnostic performance of the screening protocol was excellent with a sensitivity and specificity of 100%/100% and 89%/98% (cut-off ≥ PI-RADS 4) for reader 1 (R1) and reader 2 (R2), respectively. Mean image quality was 3.96 (R1) and 4.35 (R2) for the standard protocol vs. 4.74 and 4.57 for the screening protocol (p < 0.05). Inter-reader agreement was moderate (κ: 0.55) for the screening protocol and substantial (κ: 0.61) for the multiparametric protocol.
The ultra-fast screening protocol showed similar diagnostic performance and better imaging quality compared to the mpMRI in under 15% of scan time, improving efficacy and enabling the implementation of screening protocols in clinical routine.
The ultra-fast protocol enables examinations without contrast administration, drastically reducing scan time to 3.5 min with similar diagnostic performance and better imaging quality. This facilitates patient-friendly, efficient examinations and addresses the conflict of increasing demand for examinations at currently exhausted capacities.
Time-consuming MRI protocols are in conflict with an expected increase in examinations required for prostate cancer screening. An ultra-fast MRI protocol shows similar performance and better image quality compared to the standard protocol. Deep-learning acceleration facilitates efficient and patient-friendly examinations, thus improving prostate cancer screening capacity.
与标准多参数(mp)方案相比,建立并评估一种用于前列腺癌(PCa)的超快 MRI 筛查方案,以减少扫描时间并保持足够的诊断性能。
本前瞻性单中心研究纳入了 2022 年 12 月至 2023 年 3 月期间疑似患有 PCa 的连续活检初治患者。在 3T 扫描仪上采集 PI-RADSv2.1 符合的 mpMRI 方案(扫描时间:25 分 45 秒)。此外,还采集了两个深度学习(DL)加速序列(T2 和扩散加权),作为筛查方案(扫描时间:3 分 28 秒)。两位读者在两次会议中根据 PI-RADSv2.1 评分评估图像质量和 PCa 的可能性。根据 mpMRI 作为参考标准,得出筛查方案的诊断性能。使用加权 kappa 统计评估读者间和读者内的一致性。
我们纳入了 77 名患者的 97 个病灶(平均年龄:66 岁;标准差:7.7)。筛查方案的诊断性能优异,读者 1(R1)和读者 2(R2)的敏感性和特异性分别为 100%/100%和 89%/98%(截断值≥PI-RADS 4)。标准方案的平均图像质量为 3.96(R1)和 4.35(R2),而筛查方案的图像质量为 4.74 和 4.57(p<0.05)。筛查方案的读者间一致性为中度(κ:0.55),多参数方案的读者间一致性为高度(κ:0.61)。
与 mpMRI 相比,超快筛查方案在扫描时间减少 15%的情况下显示出相似的诊断性能和更好的图像质量,提高了效率,并使筛查方案能够在临床常规中实施。
超快方案能够进行无需造影剂的检查,将扫描时间大幅缩短至 3.5 分钟,同时保持相似的诊断性能和更好的图像质量。这有助于实现患者友好、高效的检查,并解决当前检查能力耗尽情况下对检查需求增加的矛盾。
耗时的 MRI 方案与预计用于前列腺癌筛查的检查次数增加相冲突。超快 MRI 方案与标准方案相比,具有相似的性能和更好的图像质量。深度学习加速有助于高效、方便患者的检查,从而提高前列腺癌筛查能力。